Titre : Système hématopoïétique

Système hématopoïétique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Healthcare Failure Mode and Effect Analysis

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une anémie?

Un test sanguin mesure le taux d'hémoglobine et d'hématocrite.
Anémie Hémoglobine
#2

Quels tests pour les troubles de la coagulation?

Les tests de temps de prothrombine et de temps de thromboplastine partielle sont utilisés.
Troubles de la coagulation Thromboplastine
#3

Comment détecter une leucémie?

Une analyse de sang et une biopsie de moelle osseuse sont nécessaires.
Leucémie Biopsie de moelle osseuse
#4

Quels signes indiquent une thrombocytopénie?

Des saignements faciles et des ecchymoses fréquentes peuvent indiquer une thrombocytopénie.
Thrombocytopénie Saignement
#5

Quel rôle joue l'électrophorèse des protéines?

Elle aide à identifier les anomalies des protéines sanguines, comme dans le myélome.
Électrophorèse des protéines Myélome

Symptômes 5

#1

Quels sont les symptômes d'une anémie?

Fatigue, pâleur, essoufflement et palpitations sont des symptômes courants.
Anémie Fatigue
#2

Comment reconnaître une leucémie?

Symptômes incluent fièvre, fatigue, infections fréquentes et ecchymoses.
Leucémie Infections
#3

Quels signes d'une thrombose?

Douleur, gonflement et rougeur dans la zone affectée peuvent indiquer une thrombose.
Thrombose Douleur
#4

Quels symptômes d'une polycythémie?

Rougeur de la peau, démangeaisons et maux de tête fréquents peuvent survenir.
Polycythémie Démangeaisons
#5

Quels symptômes d'une infection sanguine?

Fièvre, frissons, confusion et fatigue intense sont des signes d'infection sanguine.
Infection sanguine Fièvre

Prévention 5

#1

Comment prévenir l'anémie?

Une alimentation riche en fer et en vitamines est essentielle pour prévenir l'anémie.
Anémie Alimentation
#2

Quelles mesures pour éviter les infections sanguines?

Maintenir une bonne hygiène et se faire vacciner aide à prévenir les infections.
Infections sanguines Vaccination
#3

Comment réduire le risque de thrombose?

Rester actif, éviter le tabac et maintenir un poids santé sont des mesures préventives.
Thrombose Poids santé
#4

Quelles précautions pour les patients leucémiques?

Éviter les foules et se laver fréquemment les mains pour prévenir les infections.
Leucémie Prévention des infections
#5

Comment prévenir la polycythémie?

Éviter le tabac et gérer les maladies sous-jacentes peut aider à prévenir la polycythémie.
Polycythémie Tabac

Traitements 5

#1

Comment traiter l'anémie ferriprive?

Des suppléments de fer et des modifications alimentaires sont recommandés.
Anémie ferriprive Suppléments de fer
#2

Quel traitement pour la leucémie?

Chimiothérapie, radiothérapie et greffe de moelle osseuse sont des options.
Leucémie Chimiothérapie
#3

Comment traiter une thrombocytopénie?

Le traitement dépend de la cause; parfois, des transfusions plaquettaires sont nécessaires.
Thrombocytopénie Transfusions plaquettaires
#4

Quel traitement pour la polycythémie vera?

La phlébotomie et les médicaments pour réduire la production de globules rouges sont utilisés.
Polycythémie vera Phlébotomie
#5

Comment gérer une infection sanguine?

Des antibiotiques intraveineux sont souvent nécessaires pour traiter l'infection.
Infection sanguine Antibiotiques

Complications 5

#1

Quelles complications de l'anémie?

Des complications peuvent inclure des problèmes cardiaques et des troubles cognitifs.
Anémie Complications cardiaques
#2

Quels risques liés à la leucémie?

Les patients peuvent développer des infections graves et des saignements excessifs.
Leucémie Infections graves
#3

Quelles complications de la thrombocytopénie?

Des saignements internes et externes peuvent survenir, mettant la vie en danger.
Thrombocytopénie Saignements
#4

Quels risques de la polycythémie vera?

Elle peut entraîner des complications thromboemboliques, comme des AVC ou des crises cardiaques.
Polycythémie vera AVC
#5

Quelles complications des infections sanguines?

Des complications graves incluent le choc septique et la défaillance multiviscérale.
Infections sanguines Choc septique

Facteurs de risque 5

#1

Quels facteurs de risque pour l'anémie?

Une mauvaise alimentation, des maladies chroniques et des pertes sanguines fréquentes augmentent le risque.
Anémie Maladies chroniques
#2

Quels facteurs de risque pour la leucémie?

L'exposition à des radiations et certains produits chimiques peuvent augmenter le risque.
Leucémie Radiations
#3

Quels facteurs de risque pour la thrombocytopénie?

Certaines maladies auto-immunes et infections virales peuvent contribuer à la thrombocytopénie.
Thrombocytopénie Maladies auto-immunes
#4

Quels facteurs de risque pour la polycythémie?

Le tabagisme, l'apnée du sommeil et la vie en altitude sont des facteurs de risque connus.
Polycythémie Tabagisme
#5

Quels facteurs de risque pour les infections sanguines?

Les patients immunodéprimés et ceux avec des dispositifs intraveineux sont à risque accru.
Infections sanguines Immunodéprimés
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Système hématopoïétique : Questions médicales les plus fréquentes", "headline": "Système hématopoïétique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Système hématopoïétique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-13", "dateModified": "2025-05-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Système hématopoïétique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Systèmes sanguin et immunitaire", "url": "https://questionsmedicales.fr/mesh/D006424", "about": { "@type": "MedicalCondition", "name": "Systèmes sanguin et immunitaire", "code": { "@type": "MedicalCode", "code": "D006424", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cellules de la moelle osseuse", "alternateName": "Bone Marrow Cells", "url": "https://questionsmedicales.fr/mesh/D001854", "about": { "@type": "MedicalCondition", "name": "Cellules de la moelle osseuse", "code": { "@type": "MedicalCode", "code": "D001854", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cellules souches hématopoïétiques", "alternateName": "Hematopoietic Stem Cells", "url": "https://questionsmedicales.fr/mesh/D006412", "about": { "@type": "MedicalCondition", "name": "Cellules souches hématopoïétiques", "code": { "@type": "MedicalCode", "code": "D006412", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Progéniteurs lymphoïdes", "alternateName": "Lymphoid Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D054503", "about": { "@type": "MedicalCondition", "name": "Progéniteurs lymphoïdes", "code": { "@type": "MedicalCode", "code": "D054503", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.550" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs myéloïdes", "alternateName": "Myeloid Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D023461", "about": { "@type": "MedicalCondition", "name": "Progéniteurs myéloïdes", "code": { "@type": "MedicalCode", "code": "D023461", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Progéniteurs des granulocytes et macrophages", "alternateName": "Granulocyte-Macrophage Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055014", "about": { "@type": "MedicalCondition", "name": "Progéniteurs des granulocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055014", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Précurseurs des granulocytes", "alternateName": "Granulocyte Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D042381", "about": { "@type": "MedicalCondition", "name": "Précurseurs des granulocytes", "code": { "@type": "MedicalCode", "code": "D042381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.500" } } }, { "@type": "MedicalWebPage", "name": "Précurseurs des monocytes et macrophages", "alternateName": "Monocyte-Macrophage Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D055017", "about": { "@type": "MedicalCondition", "name": "Précurseurs des monocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055017", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Précurseurs des granulocytes", "alternateName": "Granulocyte Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D042381", "about": { "@type": "MedicalCondition", "name": "Précurseurs des granulocytes", "code": { "@type": "MedicalCode", "code": "D042381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.500" } } }, { "@type": "MedicalWebPage", "name": "Précurseurs des monocytes et macrophages", "alternateName": "Monocyte-Macrophage Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D055017", "about": { "@type": "MedicalCondition", "name": "Précurseurs des monocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055017", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.750" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs érythroïdes et mégacaryocytaires", "alternateName": "Megakaryocyte-Erythroid Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055015", "about": { "@type": "MedicalCondition", "name": "Progéniteurs érythroïdes et mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055015", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Précurseurs érythroïdes", "alternateName": "Erythroid Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D015672", "about": { "@type": "MedicalCondition", "name": "Précurseurs érythroïdes", "code": { "@type": "MedicalCode", "code": "D015672", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs mégacaryocytaires", "alternateName": "Megakaryocyte Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055016", "about": { "@type": "MedicalCondition", "name": "Progéniteurs mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055016", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.625" } } } ] }, { "@type": "MedicalWebPage", "name": "Précurseurs érythroïdes", "alternateName": "Erythroid Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D015672", "about": { "@type": "MedicalCondition", "name": "Précurseurs érythroïdes", "code": { "@type": "MedicalCode", "code": "D015672", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs mégacaryocytaires", "alternateName": "Megakaryocyte Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055016", "about": { "@type": "MedicalCondition", "name": "Progéniteurs mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055016", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.625" } } } ] }, { "@type": "MedicalWebPage", "name": "Progéniteurs des granulocytes et macrophages", "alternateName": "Granulocyte-Macrophage Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055014", "about": { "@type": "MedicalCondition", "name": "Progéniteurs des granulocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055014", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Précurseurs des granulocytes", "alternateName": "Granulocyte Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D042381", "about": { "@type": "MedicalCondition", "name": "Précurseurs des granulocytes", "code": { "@type": "MedicalCode", "code": "D042381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.500" } } }, { "@type": "MedicalWebPage", "name": "Précurseurs des monocytes et macrophages", "alternateName": "Monocyte-Macrophage Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D055017", "about": { "@type": "MedicalCondition", "name": "Précurseurs des monocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055017", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Précurseurs des granulocytes", "alternateName": "Granulocyte Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D042381", "about": { "@type": "MedicalCondition", "name": "Précurseurs des granulocytes", "code": { "@type": "MedicalCode", "code": "D042381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.500" } } }, { "@type": "MedicalWebPage", "name": "Précurseurs des monocytes et macrophages", "alternateName": "Monocyte-Macrophage Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D055017", "about": { "@type": "MedicalCondition", "name": "Précurseurs des monocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055017", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.750" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs érythroïdes et mégacaryocytaires", "alternateName": "Megakaryocyte-Erythroid Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055015", "about": { "@type": "MedicalCondition", "name": "Progéniteurs érythroïdes et mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055015", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Précurseurs érythroïdes", "alternateName": "Erythroid Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D015672", "about": { "@type": "MedicalCondition", "name": "Précurseurs érythroïdes", "code": { "@type": "MedicalCode", "code": "D015672", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs mégacaryocytaires", "alternateName": "Megakaryocyte Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055016", "about": { "@type": "MedicalCondition", "name": "Progéniteurs mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055016", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.625" } } } ] }, { "@type": "MedicalWebPage", "name": "Précurseurs érythroïdes", "alternateName": "Erythroid Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D015672", "about": { "@type": "MedicalCondition", "name": "Précurseurs érythroïdes", "code": { "@type": "MedicalCode", "code": "D015672", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs mégacaryocytaires", "alternateName": "Megakaryocyte Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055016", "about": { "@type": "MedicalCondition", "name": "Progéniteurs mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055016", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.625" } } } ] }, { "@type": "MedicalWebPage", "name": "Progéniteurs lymphoïdes", "alternateName": "Lymphoid Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D054503", "about": { "@type": "MedicalCondition", "name": "Progéniteurs lymphoïdes", "code": { "@type": "MedicalCode", "code": "D054503", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.550" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs myéloïdes", "alternateName": "Myeloid Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D023461", "about": { "@type": "MedicalCondition", "name": "Progéniteurs myéloïdes", "code": { "@type": "MedicalCode", "code": "D023461", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Progéniteurs des granulocytes et macrophages", "alternateName": "Granulocyte-Macrophage Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055014", "about": { "@type": "MedicalCondition", "name": "Progéniteurs des granulocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055014", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Précurseurs des granulocytes", "alternateName": "Granulocyte Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D042381", "about": { "@type": "MedicalCondition", "name": "Précurseurs des granulocytes", "code": { "@type": "MedicalCode", "code": "D042381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.500" } } }, { "@type": "MedicalWebPage", "name": "Précurseurs des monocytes et macrophages", "alternateName": "Monocyte-Macrophage Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D055017", "about": { "@type": "MedicalCondition", "name": "Précurseurs des monocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055017", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Précurseurs des granulocytes", "alternateName": "Granulocyte Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D042381", "about": { "@type": "MedicalCondition", "name": "Précurseurs des granulocytes", "code": { "@type": "MedicalCode", "code": "D042381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.500" } } }, { "@type": "MedicalWebPage", "name": "Précurseurs des monocytes et macrophages", "alternateName": "Monocyte-Macrophage Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D055017", "about": { "@type": "MedicalCondition", "name": "Précurseurs des monocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055017", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.750" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs érythroïdes et mégacaryocytaires", "alternateName": "Megakaryocyte-Erythroid Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055015", "about": { "@type": "MedicalCondition", "name": "Progéniteurs érythroïdes et mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055015", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Précurseurs érythroïdes", "alternateName": "Erythroid Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D015672", "about": { "@type": "MedicalCondition", "name": "Précurseurs érythroïdes", "code": { "@type": "MedicalCode", "code": "D015672", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs mégacaryocytaires", "alternateName": "Megakaryocyte Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055016", "about": { "@type": "MedicalCondition", "name": "Progéniteurs mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055016", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.625" } } } ] }, { "@type": "MedicalWebPage", "name": "Précurseurs érythroïdes", "alternateName": "Erythroid Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D015672", "about": { "@type": "MedicalCondition", "name": "Précurseurs érythroïdes", "code": { "@type": "MedicalCode", "code": "D015672", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs mégacaryocytaires", "alternateName": "Megakaryocyte Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055016", "about": { "@type": "MedicalCondition", "name": "Progéniteurs mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055016", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.625" } } } ] }, { "@type": "MedicalWebPage", "name": "Progéniteurs des granulocytes et macrophages", "alternateName": "Granulocyte-Macrophage Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055014", "about": { "@type": "MedicalCondition", "name": "Progéniteurs des granulocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055014", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Précurseurs des granulocytes", "alternateName": "Granulocyte Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D042381", "about": { "@type": "MedicalCondition", "name": "Précurseurs des granulocytes", "code": { "@type": "MedicalCode", "code": "D042381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.500" } } }, { "@type": "MedicalWebPage", "name": "Précurseurs des monocytes et macrophages", "alternateName": "Monocyte-Macrophage Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D055017", "about": { "@type": "MedicalCondition", "name": "Précurseurs des monocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055017", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Précurseurs des granulocytes", "alternateName": "Granulocyte Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D042381", "about": { "@type": "MedicalCondition", "name": "Précurseurs des granulocytes", "code": { "@type": "MedicalCode", "code": "D042381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.500" } } }, { "@type": "MedicalWebPage", "name": "Précurseurs des monocytes et macrophages", "alternateName": "Monocyte-Macrophage Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D055017", "about": { "@type": "MedicalCondition", "name": "Précurseurs des monocytes et macrophages", "code": { "@type": "MedicalCode", "code": "D055017", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.675.750" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs érythroïdes et mégacaryocytaires", "alternateName": "Megakaryocyte-Erythroid Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055015", "about": { "@type": "MedicalCondition", "name": "Progéniteurs érythroïdes et mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055015", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Précurseurs érythroïdes", "alternateName": "Erythroid Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D015672", "about": { "@type": "MedicalCondition", "name": "Précurseurs érythroïdes", "code": { "@type": "MedicalCode", "code": "D015672", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs mégacaryocytaires", "alternateName": "Megakaryocyte Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055016", "about": { "@type": "MedicalCondition", "name": "Progéniteurs mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055016", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.625" } } } ] }, { "@type": "MedicalWebPage", "name": "Précurseurs érythroïdes", "alternateName": "Erythroid Precursor Cells", "url": "https://questionsmedicales.fr/mesh/D015672", "about": { "@type": "MedicalCondition", "name": "Précurseurs érythroïdes", "code": { "@type": "MedicalCode", "code": "D015672", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Érythroblastes", "alternateName": "Erythroblasts", "url": "https://questionsmedicales.fr/mesh/D004900", "about": { "@type": "MedicalCondition", "name": "Érythroblastes", "code": { "@type": "MedicalCode", "code": "D004900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Mégaloblastes", "alternateName": "Megaloblasts", "url": "https://questionsmedicales.fr/mesh/D008534", "about": { "@type": "MedicalCondition", "name": "Mégaloblastes", "code": { "@type": "MedicalCode", "code": "D008534", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.250.200.500" } } }, { "@type": "MedicalWebPage", "name": "Progéniteurs mégacaryocytaires", "alternateName": "Megakaryocyte Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D055016", "about": { "@type": "MedicalCondition", "name": "Progéniteurs mégacaryocytaires", "code": { "@type": "MedicalCode", "code": "D055016", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.378.590.837.625" } } }, { "@type": "MedicalWebPage", "name": "Mégacaryocytes", "alternateName": "Megakaryocytes", "url": "https://questionsmedicales.fr/mesh/D008533", "about": { "@type": "MedicalCondition", "name": "Mégacaryocytes", "code": { "@type": "MedicalCode", "code": "D008533", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.479" } } }, { "@type": "MedicalWebPage", "name": "Réticulocytes", "alternateName": "Reticulocytes", "url": "https://questionsmedicales.fr/mesh/D012156", "about": { "@type": "MedicalCondition", "name": "Réticulocytes", "code": { "@type": "MedicalCode", "code": "D012156", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.378.316.790" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Système hématopoïétique", "alternateName": "Hematopoietic System", "code": { "@type": "MedicalCode", "code": "D006413", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Maria Carolina Oliveira", "url": "https://questionsmedicales.fr/author/Maria%20Carolina%20Oliveira", "affiliation": { "@type": "Organization", "name": "Center for Cell-Based Therapy, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. mcarolor@usp.br." } }, { "@type": "Person", "name": "Xiaoliang Han", "url": "https://questionsmedicales.fr/author/Xiaoliang%20Han", "affiliation": { "@type": "Organization", "name": "Affiliated Hospital, North China University of Science and Technology Tangshan Hebei 063000 China mayastarfx2008@163.com." } }, { "@type": "Person", "name": "Fengtao Sun", "url": "https://questionsmedicales.fr/author/Fengtao%20Sun", "affiliation": { "@type": "Organization", "name": "Affiliated Hospital, North China University of Science and Technology Tangshan Hebei 063000 China mayastarfx2008@163.com." } }, { "@type": "Person", "name": "Ying Zhang", "url": "https://questionsmedicales.fr/author/Ying%20Zhang", "affiliation": { "@type": "Organization", "name": "Affiliated Hospital, North China University of Science and Technology Tangshan Hebei 063000 China mayastarfx2008@163.com." } }, { "@type": "Person", "name": "Jinyan Wang", "url": "https://questionsmedicales.fr/author/Jinyan%20Wang", "affiliation": { "@type": "Organization", "name": "Tangshan Gongren Hospital Tangshan Hebei 063000 China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Application of healthcare failure mode and effect analysis in controlling surgical instrument packaging defects.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36385494", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-24282-7" } }, { "@type": "ScholarlyArticle", "name": "Using Failure Mode and Effect Analysis to Identify Potential Failures in a Psychiatric Hospital Emergency Department.", "datePublished": "2023-05-10", "url": "https://questionsmedicales.fr/article/37162153", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/PTS.0000000000001127" } }, { "@type": "ScholarlyArticle", "name": "Use of Failure Mode and Effects Analysis (FMEA) for Risk Analysis of Drug Use in Patients with Lung Cancer.", "datePublished": "2022-11-22", "url": "https://questionsmedicales.fr/article/36497503", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph192315428" } }, { "@type": "ScholarlyArticle", "name": "Failure modes and effects analysis study for accelerator-based Boron Neutron Capture Therapy.", "datePublished": "2022-12-05", "url": "https://questionsmedicales.fr/article/36412161", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/mp.16104" } }, { "@type": "ScholarlyArticle", "name": "Failure mode and effects analysis of telehealth service of minority elderly for sustainable digital transformation.", "datePublished": "2022-08-11", "url": "https://questionsmedicales.fr/article/35973373", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.compbiomed.2022.105950" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Systèmes sanguin et immunitaire", "item": "https://questionsmedicales.fr/mesh/D006424" }, { "@type": "ListItem", "position": 3, "name": "Système hématopoïétique", "item": "https://questionsmedicales.fr/mesh/D006413" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Système hématopoïétique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Système hématopoïétique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Système hématopoïétique", "description": "Comment diagnostiquer une anémie?\nQuels tests pour les troubles de la coagulation?\nComment détecter une leucémie?\nQuels signes indiquent une thrombocytopénie?\nQuel rôle joue l'électrophorèse des protéines?", "url": "https://questionsmedicales.fr/mesh/D006413?mesh_terms=Healthcare+Failure+Mode+and+Effect+Analysis#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Système hématopoïétique", "description": "Quels sont les symptômes d'une anémie?\nComment reconnaître une leucémie?\nQuels signes d'une thrombose?\nQuels symptômes d'une polycythémie?\nQuels symptômes d'une infection sanguine?", "url": "https://questionsmedicales.fr/mesh/D006413?mesh_terms=Healthcare+Failure+Mode+and+Effect+Analysis#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Système hématopoïétique", "description": "Comment prévenir l'anémie?\nQuelles mesures pour éviter les infections sanguines?\nComment réduire le risque de thrombose?\nQuelles précautions pour les patients leucémiques?\nComment prévenir la polycythémie?", "url": "https://questionsmedicales.fr/mesh/D006413?mesh_terms=Healthcare+Failure+Mode+and+Effect+Analysis#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Système hématopoïétique", "description": "Comment traiter l'anémie ferriprive?\nQuel traitement pour la leucémie?\nComment traiter une thrombocytopénie?\nQuel traitement pour la polycythémie vera?\nComment gérer une infection sanguine?", "url": "https://questionsmedicales.fr/mesh/D006413?mesh_terms=Healthcare+Failure+Mode+and+Effect+Analysis#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Système hématopoïétique", "description": "Quelles complications de l'anémie?\nQuels risques liés à la leucémie?\nQuelles complications de la thrombocytopénie?\nQuels risques de la polycythémie vera?\nQuelles complications des infections sanguines?", "url": "https://questionsmedicales.fr/mesh/D006413?mesh_terms=Healthcare+Failure+Mode+and+Effect+Analysis#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Système hématopoïétique", "description": "Quels facteurs de risque pour l'anémie?\nQuels facteurs de risque pour la leucémie?\nQuels facteurs de risque pour la thrombocytopénie?\nQuels facteurs de risque pour la polycythémie?\nQuels facteurs de risque pour les infections sanguines?", "url": "https://questionsmedicales.fr/mesh/D006413?mesh_terms=Healthcare+Failure+Mode+and+Effect+Analysis#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anémie?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test sanguin mesure le taux d'hémoglobine et d'hématocrite." } }, { "@type": "Question", "name": "Quels tests pour les troubles de la coagulation?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de temps de prothrombine et de temps de thromboplastine partielle sont utilisés." } }, { "@type": "Question", "name": "Comment détecter une leucémie?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une analyse de sang et une biopsie de moelle osseuse sont nécessaires." } }, { "@type": "Question", "name": "Quels signes indiquent une thrombocytopénie?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements faciles et des ecchymoses fréquentes peuvent indiquer une thrombocytopénie." } }, { "@type": "Question", "name": "Quel rôle joue l'électrophorèse des protéines?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle aide à identifier les anomalies des protéines sanguines, comme dans le myélome." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une anémie?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, pâleur, essoufflement et palpitations sont des symptômes courants." } }, { "@type": "Question", "name": "Comment reconnaître une leucémie?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes incluent fièvre, fatigue, infections fréquentes et ecchymoses." } }, { "@type": "Question", "name": "Quels signes d'une thrombose?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Douleur, gonflement et rougeur dans la zone affectée peuvent indiquer une thrombose." } }, { "@type": "Question", "name": "Quels symptômes d'une polycythémie?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur de la peau, démangeaisons et maux de tête fréquents peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes d'une infection sanguine?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, confusion et fatigue intense sont des signes d'infection sanguine." } }, { "@type": "Question", "name": "Comment prévenir l'anémie?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fer et en vitamines est essentielle pour prévenir l'anémie." } }, { "@type": "Question", "name": "Quelles mesures pour éviter les infections sanguines?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et se faire vacciner aide à prévenir les infections." } }, { "@type": "Question", "name": "Comment réduire le risque de thrombose?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Rester actif, éviter le tabac et maintenir un poids santé sont des mesures préventives." } }, { "@type": "Question", "name": "Quelles précautions pour les patients leucémiques?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les foules et se laver fréquemment les mains pour prévenir les infections." } }, { "@type": "Question", "name": "Comment prévenir la polycythémie?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabac et gérer les maladies sous-jacentes peut aider à prévenir la polycythémie." } }, { "@type": "Question", "name": "Comment traiter l'anémie ferriprive?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de fer et des modifications alimentaires sont recommandés." } }, { "@type": "Question", "name": "Quel traitement pour la leucémie?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Chimiothérapie, radiothérapie et greffe de moelle osseuse sont des options." } }, { "@type": "Question", "name": "Comment traiter une thrombocytopénie?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause; parfois, des transfusions plaquettaires sont nécessaires." } }, { "@type": "Question", "name": "Quel traitement pour la polycythémie vera?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La phlébotomie et les médicaments pour réduire la production de globules rouges sont utilisés." } }, { "@type": "Question", "name": "Comment gérer une infection sanguine?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des antibiotiques intraveineux sont souvent nécessaires pour traiter l'infection." } }, { "@type": "Question", "name": "Quelles complications de l'anémie?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des problèmes cardiaques et des troubles cognitifs." } }, { "@type": "Question", "name": "Quels risques liés à la leucémie?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent développer des infections graves et des saignements excessifs." } }, { "@type": "Question", "name": "Quelles complications de la thrombocytopénie?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements internes et externes peuvent survenir, mettant la vie en danger." } }, { "@type": "Question", "name": "Quels risques de la polycythémie vera?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des complications thromboemboliques, comme des AVC ou des crises cardiaques." } }, { "@type": "Question", "name": "Quelles complications des infections sanguines?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des complications graves incluent le choc septique et la défaillance multiviscérale." } }, { "@type": "Question", "name": "Quels facteurs de risque pour l'anémie?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise alimentation, des maladies chroniques et des pertes sanguines fréquentes augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la leucémie?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition à des radiations et certains produits chimiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la thrombocytopénie?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies auto-immunes et infections virales peuvent contribuer à la thrombocytopénie." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la polycythémie?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'apnée du sommeil et la vie en altitude sont des facteurs de risque connus." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les infections sanguines?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les patients immunodéprimés et ceux avec des dispositifs intraveineux sont à risque accru." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 08/05/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

14 au total
└─

Cellules de la moelle osseuse

Bone Marrow Cells D001854 - A15.378.316
└─└─

Cellules souches hématopoïétiques

Hematopoietic Stem Cells D006412 - A15.378.316.378
└─└─

Mégacaryocytes

Megakaryocytes D008533 - A15.378.316.479
└─└─

Réticulocytes

Reticulocytes D012156 - A15.378.316.790
└─└─└─

Progéniteurs lymphoïdes

Lymphoid Progenitor Cells D054503 - A15.378.316.378.550
└─└─└─

Progéniteurs myéloïdes

Myeloid Progenitor Cells D023461 - A15.378.316.378.590
└─└─└─└─

Progéniteurs des granulocytes et macrophages

Granulocyte-Macrophage Progenitor Cells D055014 - A15.378.316.378.590.675
└─└─└─└─

Progéniteurs érythroïdes et mégacaryocytaires

Megakaryocyte-Erythroid Progenitor Cells D055015 - A15.378.316.378.590.837
└─└─└─└─└─

Précurseurs des granulocytes

Granulocyte Precursor Cells D042381 - A15.378.316.378.590.675.500
└─└─└─└─└─

Précurseurs des monocytes et macrophages

Monocyte-Macrophage Precursor Cells D055017 - A15.378.316.378.590.675.750
└─└─└─└─└─

Précurseurs érythroïdes

Erythroid Precursor Cells D015672 - A15.378.316.378.590.837.250
└─└─└─└─└─

Progéniteurs mégacaryocytaires

Megakaryocyte Progenitor Cells D055016 - A15.378.316.378.590.837.625
└─└─└─└─└─└─

Érythroblastes

Erythroblasts D004900 - A15.378.316.378.590.837.250.200
└─└─└─└─└─└─└─

Mégaloblastes

Megaloblasts D008534 - A15.378.316.378.590.837.250.200.500

Auteurs principaux

Maria Carolina Oliveira

5 publications dans cette catégorie

Affiliations :
  • Center for Cell-Based Therapy, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. mcarolor@usp.br.
  • Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Avenida dos Bandeirantes 3900, Ribeirão Preto, SP, 14048-900, Brazil. mcarolor@usp.br.

Xiaoliang Han

3 publications dans cette catégorie

Affiliations :
  • Affiliated Hospital, North China University of Science and Technology Tangshan Hebei 063000 China mayastarfx2008@163.com.

Fengtao Sun

3 publications dans cette catégorie

Affiliations :
  • Affiliated Hospital, North China University of Science and Technology Tangshan Hebei 063000 China mayastarfx2008@163.com.

Ying Zhang

3 publications dans cette catégorie

Affiliations :
  • Affiliated Hospital, North China University of Science and Technology Tangshan Hebei 063000 China mayastarfx2008@163.com.

Jinyan Wang

3 publications dans cette catégorie

Affiliations :
  • Tangshan Gongren Hospital Tangshan Hebei 063000 China.

Qingguo Liu

3 publications dans cette catégorie

Affiliations :
  • Tangshan Gongren Hospital Tangshan Hebei 063000 China.

Ping Gao

3 publications dans cette catégorie

Affiliations :
  • Affiliated Hospital, North China University of Science and Technology Tangshan Hebei 063000 China mayastarfx2008@163.com.

Shubo Zhang

3 publications dans cette catégorie

Affiliations :
  • Affiliated Hospital, North China University of Science and Technology Tangshan Hebei 063000 China mayastarfx2008@163.com.

Tomomasa Yokomizo

2 publications dans cette catégorie

Affiliations :
  • Department of Microscopic and Developmental Anatomy, Tokyo Women's Medical University.
Publications dans "Système hématopoïétique" :

Daniel Levin

2 publications dans cette catégorie

Affiliations :
  • Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

Mohammed S Osman

2 publications dans cette catégorie

Affiliations :
  • Faculty of Medicine, University of Alberta, Edmonton, AB T6G 2R7, Canada.

Caylib Durand

2 publications dans cette catégorie

Affiliations :
  • Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

Hyein Kim

2 publications dans cette catégorie

Affiliations :
  • Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Iman Hemmati

2 publications dans cette catégorie

Affiliations :
  • Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Kareem Jamani

2 publications dans cette catégorie

Affiliations :
  • Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

Jonathan G Howlett

2 publications dans cette catégorie

Affiliations :
  • Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

Kerri A Johannson

2 publications dans cette catégorie

Affiliations :
  • Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

Jason Weatherald

2 publications dans cette catégorie

Affiliations :
  • Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Faculty of Medicine, University of Alberta, Edmonton, AB T6G 2R7, Canada.

Jan Storek

2 publications dans cette catégorie

Affiliations :
  • Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

Stanislav Rybtsov

2 publications dans cette catégorie

Affiliations :
  • Centre for Cell Technology and Immunology, Sirius University of Science and Technology, Sirius, 354340 Sochi, Russia.
  • Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH8 9YL, UK.
Publications dans "Système hématopoïétique" :

Sources (10000 au total)

Using Failure Mode and Effect Analysis to Identify Potential Failures in a Psychiatric Hospital Emergency Department.

Failure mode and effect analysis (FMEA) is a powerful tool for accessing potential failures, but the participants are limited. It has not been used in psychiatric hospitals. Objectives were to impleme... In this prospective, questionnaire-based study, a multidisciplinary team experienced in ED admissions was trained in FMEA and determined potential failures in the process. They developed a questionnai... By applying FMEA, we found 6 steps of the ED admission process, with 32 potential failures. Risk priority numbers ranged from 91 to 225. The most notable potential failure identified was during a pati... Failure mode and effect analysis can be implemented in psychiatric hospitals and can be a useful tool for anticipating potential failures. The number of participants in an FMEA can be increased to inc...

Failure modes and effects analysis study for accelerator-based Boron Neutron Capture Therapy.

Boron Neutron Capture Therapy (BNCT) has recently been used in clinical oncology thanks to recent developments of accelerator-based BNCT systems. Although there are some specific processes for BNCT, t... The aim of this study is to provide comprehensive data on the risk of accelerator-based BNCT system to institutions planning to implement an accelerator-based BNCT system.... In this study, failure mode and effects analysis (FMEA) was performed based on a treatment process map prepared for the accelerator-based BNCT system. A multidisciplinary team consisting of a medical ... The identified FMs for BNCT were 165 in which 30 and 17 FMs were classified as high risk and very high risk, respectively. Additionally, 71 FMs were accelerator-based BNCT-specific FMs in which 18 and... This study is the first report for conducting a risk analysis for BNCT using FMEA. Thus, this study provides comprehensive data needed for quality assurance/quality control (QA/QC) in the treatment pr...

Failure mode and effects analysis of telehealth service of minority elderly for sustainable digital transformation.

Telehealth services are time- and cost-saving solutions for disease management for older adults. Minority older individuals with multiple risk factors have an increasing demand for telehealth services... An eight-member multidisciplinary team conducted telehealth FMEA to determine risk priority numbers (RPNs). The process included identifying the potential cause and effect failure mode of each step; m... This study identified 24 risk factors and 34 causes in four major phases with a mean RPN of 90.7: preparation to measure biosignals, measurement of biosignals following instructions from a personal de... To correct these failure modes, stabilization of the platform, adding to the providers' manpower, and support for government policies are recommended. FMEA identifies and evaluates the potential risks...

Failure modes and effects analysis of pediatric I-131 MIBG therapy: Program design and potential pitfalls.

There is growing interest among pediatric institutions for implementing iodine-131 (I-131) meta-iodobenzylguanidine (MIBG) therapy for treating children with high-risk neuroblastoma. Due to regulation... We formed a multidisciplinary team, involving pediatric oncology, radiation oncology, and radiation safety staff. To evaluate the robustness of the therapy workflow and quantitatively assess potential... A total of 176 failure modes were identified and scored. The majority (94%) of failure modes scored low (RPN <100). The highest risk failure modes were related to training and to drug-infusion procedu... Through use of FMEA methodology, we successfully identified multiple potential points of failure that have allowed us to proactively mitigate risks when implementing a pediatric MIBG program....

Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison.

The Global Clinical Trials RTQA Harmonization Group (GHG) set out to evaluate and prioritize clinical trial quality assurance.... The GHG compiled a list of radiotherapy quality assurance (QA) tests performed for proton and photon therapy clinical trials. These tests were compared between modalities to assess whether there was a... The risk analysis showed that proton and photon therapy shared four out of five of their highest-risk failures (end-to-end anthropomorphic phantom test, phantom tests using respiratory motion, pre-tre... The identification of high-risk errors associated with clinical trials is valuable to prioritize and reduce errors in radiotherapy and improve the quality of trial data and outcomes, and can be applie...

Failure Mode and Effects Analysis (FMEA) at the preanalytical phase for POCT blood gas analysis: proposal for a shared proactive risk analysis model.

Proposal of a risk analysis model to diminish negative impact on patient care by preanalytical errors in blood gas analysis (BGA).... Here we designed a Failure Mode and Effects Analysis (FMEA) risk assessment template for BGA, based on literature references and expertise of an international team of laboratory and clinical health ca... The FMEA identifies pre-analytical process steps, errors that may occur whilst performing BGA (potential failure mode), possible consequences (potential failure effect) and preventive/corrective actio... This FMEA model will help health care professionals manage and minimize the risk of preanalytical errors in BGA....

Implementing failure mode and effect analysis to improve the safety of volumetric modulated arc therapy for total body irradiation.

Volumetric-modulated arc therapy for total body irradiation (VMAT-TBI) is a novel radiotherapy technique that has been implemented at our institution. The purpose of this work is to investigate possib... We formed a multidisciplinary team to map out the complete treatment process of VMAT-TBI following the AAPM TG-100 guidelines. This process map gives a visual representation of the VMAT-TBI workflow f... We identified a total of 55 sub-processes and 128 FMs from the VMAT-TBI workflow. The top five high-risk FMs were: (1) Prescription and/or OAR constraints changed during planning and not communicated ... FM and effect analysis was performed to identify high-risk FMs of our VMAT-TBI program. FMEA and FTA were effective in identifying potential FMs and determining the best quality management (QM) measur...

Reducing perioperative red blood cell unit issue orders, returns, and waste using failure modes and effects analysis.

Surgical transfusion has an outsized impact on hospital-based transfusion services, leading to blood product waste and unnecessary costs. The objective of this study was to design and implement a stre... To address the high rates of surgical blood issue requests and red blood cell (RBC) unit waste at a large academic medical center, a failure modes and effects analysis was used to systematically exami... The number of perioperative RBC unit issue requests decreased from 358 per month (SD 24) pre-intervention to 282 per month (SD 16) post-intervention (p < .001), resulting in an estimated savings of 8.... Our intervention, designed based on a structured failure modes analysis, achieved sustained reductions in perioperative RBC unit issue orders, returns, and waste, with associated benefits for blood co...